Tag: Nasdaq:SENS

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:SENS

D3PUBLISHER Announces EARTH DEFENSE FORCE 5 and EARTH DEFENSE FORCE 6 for Nintendo Switch 2

Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering

GENISOM AI Debuts at ICRA 2026 with Full-Stack Embodied Intelligence System

Tag: Nasdaq:SENS

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us